[go: up one dir, main page]

ITMI912995A0 - Forma cristallina di un antibiotico cefalosforino - Google Patents

Forma cristallina di un antibiotico cefalosforino

Info

Publication number
ITMI912995A0
ITMI912995A0 IT91MI2995A ITMI912995A ITMI912995A0 IT MI912995 A0 ITMI912995 A0 IT MI912995A0 IT 91MI2995 A IT91MI2995 A IT 91MI2995A IT MI912995 A ITMI912995 A IT MI912995A IT MI912995 A0 ITMI912995 A0 IT MI912995A0
Authority
IT
Italy
Prior art keywords
cephalosphorin
antibiotic
crystalline form
crystalline
cephalosphorin antibiotic
Prior art date
Application number
IT91MI2995A
Other languages
English (en)
Inventor
Col Marco Da
Asta Leone Dall
Irene Resta
Original Assignee
Opos Biochimica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opos Biochimica Srl filed Critical Opos Biochimica Srl
Publication of ITMI912995A0 publication Critical patent/ITMI912995A0/it
Priority to ITMI912995A priority Critical patent/IT1251999B/it
Priority to AT92203375T priority patent/ATE166878T1/de
Priority to EP92203375A priority patent/EP0547646B1/en
Priority to DE69225782T priority patent/DE69225782D1/de
Priority to CA002082472A priority patent/CA2082472A1/en
Priority to JP4301282A priority patent/JPH05222056A/ja
Publication of ITMI912995A1 publication Critical patent/ITMI912995A1/it
Application granted granted Critical
Publication of IT1251999B publication Critical patent/IT1251999B/it
Priority to US08/455,136 priority patent/US5693790A/en
Priority to US08/483,888 priority patent/US5589593A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI912995A 1991-11-11 1991-11-11 Forma cristallina di un antibiotico cefalosporinico IT1251999B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITMI912995A IT1251999B (it) 1991-11-11 1991-11-11 Forma cristallina di un antibiotico cefalosporinico
AT92203375T ATE166878T1 (de) 1991-11-11 1992-11-04 Kristalline form eines antibiotischen cephalosporins
EP92203375A EP0547646B1 (en) 1991-11-11 1992-11-04 Crystalline form of a cephalosporin antibiotic
DE69225782T DE69225782D1 (de) 1991-11-11 1992-11-04 Kristalline Form eines antibiotischen Cephalosporins
CA002082472A CA2082472A1 (en) 1991-11-11 1992-11-09 Crystalline form of a cephalosporin antibiotic
JP4301282A JPH05222056A (ja) 1991-11-11 1992-11-11 セファロスポリン抗生物質の結晶性形状
US08/455,136 US5693790A (en) 1991-11-11 1995-05-31 Crystalline form of a cephalosporin antibiotic
US08/483,888 US5589593A (en) 1991-11-11 1995-06-07 Crystalline form of a cephalosporin antibiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912995A IT1251999B (it) 1991-11-11 1991-11-11 Forma cristallina di un antibiotico cefalosporinico

Publications (3)

Publication Number Publication Date
ITMI912995A0 true ITMI912995A0 (it) 1991-11-11
ITMI912995A1 ITMI912995A1 (it) 1993-05-11
IT1251999B IT1251999B (it) 1995-05-27

Family

ID=11361068

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912995A IT1251999B (it) 1991-11-11 1991-11-11 Forma cristallina di un antibiotico cefalosporinico

Country Status (7)

Country Link
US (1) US5693790A (it)
EP (1) EP0547646B1 (it)
JP (1) JPH05222056A (it)
AT (1) ATE166878T1 (it)
CA (1) CA2082472A1 (it)
DE (1) DE69225782D1 (it)
IT (1) IT1251999B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
KR100367564B1 (ko) * 1997-08-25 2003-01-14 오츠카 가가쿠 가부시키 가이샤 세파로스포린 결정 및 그의 제조방법
AU4441899A (en) * 1999-05-14 2000-12-05 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
US6596307B1 (en) 1999-06-15 2003-07-22 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
CN1329391C (zh) * 2003-06-13 2007-08-01 清华大学 一种有机光致变色二芳基乙烯化合物及其制备方法与应用
KR101335798B1 (ko) 2005-02-15 2013-12-02 듀크 유니버시티 항-ｃｄ19 항체 및 종양학에서 이의 용도
CN101550152B (zh) * 2009-05-07 2011-05-04 郑仙锋 一种头孢克洛化合物及其制法
CN101805357B (zh) * 2010-04-28 2012-01-11 陶灵刚 一种头孢克洛化合物及其制法
CN111057072A (zh) * 2019-12-16 2020-04-24 广州维奥康药业科技有限公司 一种头孢克洛杂质去除方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US4898938A (en) * 1987-08-03 1990-02-06 Rifar S.R.L. Method for preparing crystalline cefadroxil monohydrate
US5142042A (en) * 1989-01-23 1992-08-25 Purzer Pharmaceutical Co., Ltd. Process for preparing well crystallized alkali metal salts of 3, 7-substituted 7-aminocephalosporanic acid derivatives
IT1239268B (it) * 1989-12-01 1993-10-01 I R C A Ind Ricerche Chimiche Procedimento per la preparazione dell'acido 7-(d-2-amino-2-fenilacetamido)-3-cloro-3-cefem-4-carbossilico monoidrato e intermedio
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic

Also Published As

Publication number Publication date
EP0547646A3 (en) 1993-09-22
ITMI912995A1 (it) 1993-05-11
EP0547646B1 (en) 1998-06-03
DE69225782D1 (de) 1998-07-09
ATE166878T1 (de) 1998-06-15
JPH05222056A (ja) 1993-08-31
EP0547646A2 (en) 1993-06-23
CA2082472A1 (en) 1993-05-12
IT1251999B (it) 1995-05-27
US5693790A (en) 1997-12-02

Similar Documents

Publication Publication Date Title
ATE212630T1 (de) Kristallinische oxathiolanderivate
DE4396033T1 (de) Ein Palettierer
DE69311223D1 (de) Formbare kristalline Polyesterzusammensetzung
FI924210A7 (fi) Kiteisen peneemin valmistus
FI925314A7 (fi) Cefalosporinderivat
NO303938B1 (no) Antibiotiske forbindelser
ITMI912995A0 (it) Forma cristallina di un antibiotico cefalosforino
FI941942A7 (fi) Kiteinen spirostanyyliglykosidaali-monohydraatti
FI935063L (fi) Kristallint karbapenemderivat
MX9205838A (es) Compuesto fluidificante
BR9005812A (pt) Poliimidossiloxanos cristalinos
FI923310A7 (fi) Pradimisiiniantibioottien tuotanto
ITMI912014A1 (it) Procedimento per il recupero di un antibiotico tetraciclinico
NO930834D0 (no) Anvendelse av et 2-deoksystreptamin-type antibiotikum
IT225865Y1 (it) Forma particolare
IT229641Y1 (it) Profilato di attacco a parete
KR930006844U (ko) 장식용 벽돌
ITMI931435A1 (it) Forma cristallina a densita' elevata della pentossifillina
IT9021052A0 (it) Procedimento per il recupero di un antibiotico tetraciclinico
IT227001Y1 (it) Contenitore portaoggetti a forma di succhiotto
GB9119137D0 (en) A curtain wall structure
BR9104689A (pt) Composto higienizante
BR7100474U (pt) Disposicao em forma
IT1238425B (it) Rompicapo a forma di dodecaedro regolare
DK191391D0 (da) Vaegkonstruktion

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971127